References
- Gómez Perosanz M, Russo G, Lopez JLS-T, et al. Computational immunogenetics, encyclopedia of bioinformatics and computational biology. New York: Academic Press; 2019; p. 906–930.
- Raghupathy R, Makhseed M, Azizieh F, et al. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol. 1999;196(2):122–130.
- La Rocca C, Carbone F, Longobardi S, et al. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett. 2014;162(1 Pt A):41–48.
- Wang WJ, Hao CF, Yi-Lin G-J, et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol. 2010;84(2):164–170.
- Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(3):429–438.
- Huang YH, Zhang W, Cai H, et al. Zhou CD200/CD200R expression levels and its significance after allogeneic hematopoietic stem cell Transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24(3):815–820.
- Prodeus A, Cydzik M, Abdul-Wahid A, et al. Agonistic CD200R1 DNA aptamers are potent immunosuppressants that prolong allogeneic skin graft survival. Mol Ther Nucleic Acids. 2014;3(8):e190.
- Nathan C, Muller WA. Putting the brakes on innate immunity: a regulatory role for CD200? Nat Immunol. 2001;2(1):17–19.
- Rygiel TP, Karnam G, Goverse G, et al. CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor. Oncogene. 2012;31(24):2979–2988.
- Clark DA, Arredondo JL, Dhesy-Thind S. The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in periimplant decidua by 5 weeks’ gestation. J Reprod Immunol. 2015;112:20–23.
- Wang LQ, Yan CF, Zhao Y, et al. Reduced CD200 and CD200R1 expression in human chorionic villi contributes to early spontaneous abortion. Acta Obstet Gynecol Scand. 2014;93(12):1248–1254.
- Clark DA, Keil A, Chen Z, et al. Placental trophoblast from successful human pregnancies expresses the tolerance signaling molecule, CD200 (OX-2). Am J Reprod Immunol. 2003;50(3):187–195.
- Clark DA, Dmetrichuk JM, McCready E, et al. Changes in expression of the CD200 tolerance-signaling molecule and its receptor (CD200R) by villus trophoblasts during first trimester missed abortion and in chronic histiocytic intervillositis. Am J Reprod Immunol. 2017;78(1):e12665.
- Clark DA, Ding JW, Yu G, et al. Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod. 2001;7(2):185–194.
- Petroff MG, Chen L, Phillips TA, et al. B7 family molecules: novel immunomodulators at the maternal-fetal interface. Placenta. 2002;23(Suppl A):S95–S101.
- Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring’s health. Nat Med. 2013;19(5):548–556.
- Svensson-Arvelund J, Ernerudh J, Buse E, et al. The placenta in toxicology. part II: systemic and local immune adaptations in pregnancy. Toxicol Pathol. 2014;42(2):327–338.
- Mousavinezhad-Moghaddam M, Amin AA, Rafatpanah H, et al. A new insight into viral proteins as Immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory protein. Iran J Basic Med Sci. 2016;19(1):2–13.
- Clark DA, Yu G, Levy GA, et al. Procoagulants in fetus rejection: the role of the OX-2 (CD200) tolerance signal. Semin Immunol. 2001;13(4):255–263.
- Gorczynski RM, Yu K, Clark D. Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo. J Immunol. 2000;165(9):4854–4860.
- Gorczynski RM, Cattral MS, Chen Z, et al. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol. 1999;163(3):1654–1660.
- Darmochwal-Kolarz DA, Kludka-Sternik M, Chmielewski T, et al. The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy. Am J Reprod Immunol. 2012;67(6):474–481.
- Yu G, Sun Y, Foerster K, et al. LPS-induced murine abortions require C5 but not C3, and are prevented by upregulating expression of the CD200 tolerance signaling molecule. Am J Reprod Immunol. 2008;60(2):135–140.
- Clark DA. Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Am J Reprod Immunol. 2009;61(1):75–84.
- Huang C, Zhang H, Chen X, et al. Association of peripheral blood dendritic cells with recurrent pregnancy loss: a case-controlled study. Am J Reprod Immunol. 2016;76(4):326–332.
- Chen Z, Yu K, Zhu F, et al. Over-expression of CD200 protects mice from dextran sodium sulfate induced colitis. PLoS One. 2016;11(2):e0146681.
- Xu J, Gu Y, Sun J, et al. Reduced CD200 expression is associated with altered Th1/Th2 cytokine production in placental trophoblasts from preeclampsia. Am J Reprod Immunol. 2018;79(1):e12763.